Perturbation of the EphA2-ephrinA1 system in human prostate cancer cells by colonic (Poly)phenol catabolites

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 36, 2012, Pages 8877-8884

  Tognolini, Massimiliano ^a   Giorgio, Carmine ^a   Hassan Mohamed, Iftiin ^a   Barocelli, Elisabetta ^a   Calani, Luca ^a   Reynaud, Eric ^b   Dangles, Olivier ^b   Borges, Gina ^c   Crozier, Alan ^c   Brighenti, Furio ^a   Del Rio, Daniele ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UMR A 408 INRA University of Avignon   (France)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

cancer; colonic catabolites; dietary (poly)phenols; Eph kinases; ephrin; human microbiome

Indexed keywords

CANCER; COLONIC CATABOLITES; EPH KINASES; EPHRIN; HUMAN MICROBIOME;

AMINO ACIDS; DISEASES; PHOSPHORYLATION;

PHENOLS;

EPHRIN A1; EPHRIN RECEPTOR A2; POLYPHENOL;

COLON; CONFERENCE PAPER; HUMAN; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; COLON; EPHRIN-A1; HUMANS; MALE; POLYPHENOLS; PROSTATIC NEOPLASMS; RECEPTOR, EPHA2;

EID: 84865014512     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf205305m     Document Type: Conference Paper

References (46)

1. Kullander, K.; Klein, R. Mechanisms and functions of Eph and ephrin signalling Nat. Rev. Mol. Cell Biol. 2002, 3, 475-486
2. Pasquale, E. B. Eph receptor signalling casts a wide net on cell behaviour Nat. Rev. Mol. Cell Biol. 2005, 6, 462-475
3. Surawska, H.; Ma, P. C.; Salgia, R. The role of ephrins and Eph receptors in cancer Cytokine Growth Factor Rev. 2004, 15, 419-433
4. Pasquale, E. B. Eph-ephrin bidirectional signaling in physiology and disease Cell 2008, 133, 3852
5. Pasquale, E. B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond Nat. Rev. Cancer 2010, 10, 165-180
6. Walker-Daniels, J.; Hess, A. R.; Hendrix, M. J.; Kinch, M. S. Differential regulation of EphA2 in normal and malignant cells Am. J. Pathol. 2003, 162, 1037-1042
7. Landen, C. N., Jr.; Lu, C.; Han, L. Y.; Coffman, K. T.; Bruckheimer, E.; Halder, J.; Mangala, L. S.; Merritt, W. M.; Lin, Y. G.; Gao, C.; Schmandt, R.; Kamat, A. A.; Li, Y.; Thaker, P.; Gershenson, D. M.; Parikh, N. U.; Gallick, G. E.; Kinch, M. S.; Sood, A. K. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer J. Natl. Cancer Inst. 2006, 98, 1558-1570
8. Tandon, M.; Vemula, S. V.; Mittal, S. K. Emerging strategies for EphA2 receptor targeting for cancer therapeutics Expert Opin. Ther. Targets 2011, 15, 31-51
9. Margaryan, N. V.; Strizzi, L.; Abbott, D. E.; Seftor, E. A.; Rao, M. S.; Hendrix, M. J.; Hess, A. R. EphA2 as a promoter of melanoma tumorigenicity Cancer Biol. Ther. 2009, 8, 279-288
10. Ogawa, K.; Pasqualini, R.; Lindberg, R. A.; Kain, R.; Freeman, A. L.; Pasquale, E. B. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization Oncogene 2000, 19, 6043-6052
11. Brantley, D. M.; Cheng, N.; Thompson, E. J.; Lin, Q.; Brekken, R. A.; Thorpe, P. E.; Muraoka, R. S.; Cerretti, D. P.; Pozzi, A.; Jackson, D.; Lin, C.; Chen, J. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo Oncogene 2002, 21, 7011-7026
12. Brantley-Sieders, D. M.; Chen, J. Eph receptor tyrosine kinases in angiogenesis: from development to disease Angiogenesis 2004, 7, 17-28
13. Du, J.; Fu, C.; Sretavan, D. W. Eph/ephrin signaling as a potential therapeutic target after central nervous system injury Curr. Pharm. Des. 2007, 13, 2507-2518
14. Konstantinova, I.; Nikolova, G.; Ohara-Imaizumi, M.; Meda, P.; Kucera, T.; Zarbalis, K.; Wurst, W.; Nagamatsu, S.; Lammert, E. EphA-Ephrin-A-mediated β cell communication regulates insulin secretion from pancreatic islets Cell 2007, 129, 359-370
15. Mohamed, I. H.; Giorgio, C.; Bruni, R.; Flammini, L.; Barocelli, E.; Rossi, D.; Domenichini, G.; Poli, F.; Tognolini, M. Polyphenol-rich botanicals used as food supplements interfere with EphA2-ephrinA1 system Pharmacol. Res. 2011, 64, 464-470
16. Riboli, E.; Norat, T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk Am. J. Clin. Nutr. 2003, 78, 559S-569S
17. Crozier, A.; Jaganath, I. B.; Clifford, M. N. Dietary phenolics: chemistry, bioavailability and effects on health Nat. Prod. Rep. 2009, 26, 1001-1043
18. Del Rio, D.; Borges, G.; Crozier, A. Berry flavonoids and phenolics: bioavailability and evidence of protective effects Br. J. Nutr. 2010, 104 (Suppl. 3) S67-S90
19. Dall'Asta, M.; Calani, L.; Tedeschi, M.; Jechiu, L.; Brighenti, F.; Del Rio, D. Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources Nutrition 2012, 28, 197-203
20. van Duynhoven, J.; Vaughan, E. E.; Jacobs, D. M.; Kemperman, R. A.; van Velzen, E. J.; Gross, G.; Roger, L. C.; Possemiers, S.; Smilde, A. K.; Dore, J.; Westerhuis, J. A.; Van de Wiele, T. Metabolic fate of polyphenols in the human superorganism Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (Suppl. 1) 4531-4538
21. Bialonska, D.; Kasimsetty, S. G.; Khan, S. I.; Ferreira, D. Urolithins, intestinal microbial metabolites of pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay J. Agric. Food Chem. 2009, 57, 10181-10186
22. Giorgio, C.; Hassan Mohamed, I.; Flammini, L.; Barocelli, E.; Incerti, M.; Lodola, A.; Tognolini, M. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation PLoS One 2011, 6, e18128
23. Webb, J. L. Effect of More Than One Inhibitor. Enzyme and Metabolic Inhibitors; Academic Press: New York, 1963.
24. Forester, S. C.; Waterhouse, A. L. Identification of Cabernet Sauvignon anthocyanin gut microflora metabolites J. Agric. Food Chem. 2008, 56, 9299-9304
25. Mennen, L. I.; Sapinho, D.; Ito, H.; Galan, P.; Hercberg, S.; Scalbert, A. Urinary excretion of 13 dietary flavonoids and phenolic acids in free-living healthy subjects - variability and possible use as biomarkers of polyphenol intake Eur. J. Clin. Nutr. 2008, 62, 519-525
26. Caccetta, R. A.; Croft, K. D.; Beilin, L. J.; Puddey, I. B. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability Am. J. Clin. Nutr. 2000, 71, 67-74
27. Ward, N. C.; Croft, K. D.; Puddey, I. B.; Hodgson, J. M. Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans J. Agric. Food Chem. 2004, 52, 5545-5549
28. Loke, W. M.; Jenner, A. M.; Proudfoot, J. M.; McKinley, A. J.; Hodgson, J. M.; Halliwell, B.; Croft, K. D. A metabolite profiling approach to identify biomarkers of flavonoid intake in humans J. Nutr. 2009, 139, 2309-2314
29. Selma, M. V.; Espin, J. C.; Tomas-Barberan, F. A. Interaction between phenolics and gut microbiota: role in human health J. Agric. Food Chem. 2009, 57, 6485-6501
30. Roowi, S.; Stalmach, A.; Mullen, W.; Lean, M. E.; Edwards, C. A.; Crozier, A. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans J. Agric. Food Chem. 2010, 58, 1296-1304
31. Stoupi, S.; Williamson, G.; Drynan, J. W.; Barron, D.; Clifford, M. N. A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota Mol. Nutr. Food Res. 2010, 54, 747-759
32. Nurmi, A.; Nurmi, T.; Mursu, J.; Hiltunen, R.; Voutilainen, S. Ingestion of oregano extract increases excretion of urinary phenolic metabolites in humans J. Agric. Food Chem. 2006, 54, 6916-6923
33. Miao, H.; Burnett, E.; Kinch, M.; Simon, E.; Wang, B. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation Nat. Cell Biol. 2000, 2, 62-69
34. Tanaka, M.; Kamata, R.; Sakai, R. EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability J. Biol. Chem. 2005, 280, 42375-42382
35. Chang, Q.; Jorgensen, C.; Pawson, T.; Hedley, D. W. Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer Br. J. Cancer 2008, 99, 1074-1082
36. John, K.; Ragavan, N.; Pratt, M. M.; Singh, P. B.; Al-Buheissi, S.; Matanhelia, S. S.; Phillips, D. H.; Poirier, M. C.; Martin, F. L. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate Prostate 2009, 69, 505-519
37. Baell, J. B.; Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays J. Med. Chem. 2010, 53, 2719-2740
38. Azzini, E.; Vitaglione, P.; Intorre, F.; Napolitano, A.; Durazzo, A.; Foddai, M. S.; Fumagalli, A.; Catasta, G.; Rossi, L.; Venneria, E.; Raguzzini, A.; Palomba, L.; Fogliano, V.; Maiani, G. Bioavailability of strawberry antioxidants in human subjects Br. J. Nutr. 2010, 104, 1165-1173
39. Vitaglione, P.; Donnarumma, G.; Napolitano, A.; Galvano, F.; Gallo, A.; Scalfi, L.; Fogliano, V. Protocatechuic acid is the major human metabolite of cyanidin-glucosides J. Nutr. 2007, 137, 2043-2048
40. Calani, L.; Del Rio, D.; Callegari, M. L.; Morelli, L.; Brighenti, F. Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans. Int. J. Food Sci. Nutr. 2011, DOI: 10.3109/09637486.2011.640311 (http://informahealthcare.com/doi/abs/10.3109/09637486.2011.640311, accessed Dec 2, 2011).
41. Stalmach, A.; Troufflard, S.; Serafini, M.; Crozier, A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans Mol. Nutr. Food Res. 2009, 53 (Suppl. 1) S44-S53
42. Gill, C. I.; McDougall, G. J.; Glidewell, S.; Stewart, D.; Shen, Q.; Tuohy, K.; Dobbin, A.; Boyd, A.; Brown, E.; Haldar, S.; Rowland, I. R. Profiling of phenols in human fecal water after raspberry supplementation J. Agric. Food Chem. 2010, 58, 10389-10395
43. Walker-Daniels, J.; Coffman, K.; Azimi, M.; Rhim, J. S.; Bostwick, D. G.; Snyder, P.; Kerns, B. J.; Waters, D. J.; Kinch, M. S. Overexpression of the EphA2 tyrosine kinase in prostate cancer Prostate 1999, 41, 275-280
44. Wang, X. D.; Reeves, K.; Luo, F. R.; Xu, L. A.; Lee, F.; Clark, E.; Huang, F. Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring Genome Biol. 2007, 8, R255
45. Larrosa, M.; Luceri, C.; Vivoli, E.; Pagliuca, C.; Lodovici, M.; Moneti, G.; Dolara, P. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models Mol. Nutr. Food Res. 2009, 53, 1044-1054
46. Gonzalez-Sarrias, A.; Larrosa, M.; Tomas-Barberan, F. A.; Dolara, P.; Espin, J. C. NF-κB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts Br. J. Nutr. 2010, 104, 503-512